Negative feedback between secretory and cytosolic phospholipase A2 and their opposing roles in ovalbumin-induced bronchoconstriction in rats
- 1 March 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 288 (3) , L523-L529
- https://doi.org/10.1152/ajplung.00199.2004
Abstract
Phospholipase A2 (PLA2) hydrolyzes cell membrane phospholipids (PL) to produce arachidonic acid and lyso-PL. The PLA2 enzymes include the secretory (sPLA2) and cytosolic (cPLA2) isoforms, which are assumed to act synergistically in production of eicosanoids that are involved in inflammatory processes. However, growing evidence raises the possibility that in airways and asthma-related inflammatory cells (eosinophils, basophils), the production of the bronchoconstrictor cysteinyl leukotrienes (CysLT) is linked exclusively to sPLA2, whereas the bronchodilator prostaglandin PGE2 is produced by cPLA2. It has been further reported that the capacity of airway epithelial cells to produce CysLT is inversely proportional to PGE2 production. This seems to suggest that sPLA2 and cPLA2 play opposing roles in asthma pathophysiology and the possibility of a negative feedback between the two isoenzymes. To test this hypothesis, we examined the effect of a cell-impermeable extracellular sPLA2 inhibitor on bronchoconstriction and PLA2 expression in rats with ovalbumin (OVA)-induced asthma. It was found that OVA-induced bronchoconstriction was associated with elevation of lung sPLA2 expression and CysLT production, concomitantly with suppression of cPLA2 expression and PGE2 production. These were reversed by treatment with the sPLA2 inhibitor, resulting in amelioration of bronchoconstriction and reduced CysLT production and sPLA2 expression, concomitantly with enhanced PGE2 production and cPLA2 expression. This study demonstrates, for the first time in vivo, a negative feedback between sPLA2 and cPLA2 and assigns opposing roles for these enzymes in asthma pathophysiology: sPLA2 activation induces production of the bronchoconstrictor CysLT and suppresses cPLA2 expression and the subsequent production of the bronchodilator PGE2.Keywords
This publication has 40 references indexed in Scilit:
- A novel role for phospholipase A2isoforms in the checkpoint control of acute inflammationThe FASEB Journal, 2004
- Amelioration of endotoxin-induced sepsis in rats by membrane anchored lipid conjugatesCritical Care Medicine, 2003
- Functional Coupling between Secretory and Cytosolic Phospholipase A2 Modulates Tumor Necrosis Factor-α- and Interleukin-1β-induced NF-κB ActivationPublished by Elsevier ,2001
- Group V Phospholipase A2-mediated Oleic Acid Mobilization in Lipopolysaccharide-stimulated P388D1MacrophagesPublished by Elsevier ,2000
- Phosphorylation of Cytosolic Group IV Phospholipase A2 Is Necessary but Not Sufficient for Arachidonic Acid Release in P388D1 MacrophagesBiochemical and Biophysical Research Communications, 2000
- Inhibition of Type I and Type II Phospholipase A2 by Phosphatidyl-Ethanolamine Linked to Polymeric CarriersBiochemistry, 1998
- Noninvasive Measurement of Airway Responsiveness in Allergic Mice Using Barometric PlethysmographyAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Effects of a Potent Platelet-activating Factor Antagonist, SR27417A, on Allergen-induced Asthmatic ResponsesAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics.American Journal of Respiratory and Critical Care Medicine, 1997
- Antigen-induced generation of lyso-phospholipids in human airways.The Journal of Experimental Medicine, 1996